Pacific Capital Partners LTD Standard Biotools Inc. Transaction History
Pacific Capital Partners LTD
- $107 Billion
- Q2 2025
A detailed history of Pacific Capital Partners LTD transactions in Standard Biotools Inc. stock. As of the latest transaction made, Pacific Capital Partners LTD holds 1,375,000 shares of LAB stock, worth $1.91 Million. This represents 1.55% of its overall portfolio holdings.
Number of Shares
1,375,000
Previous 1,575,000
12.7%
Holding current value
$1.91 Million
Previous $1.7 Billion
3.0%
% of portfolio
1.55%
Previous 1.08%
Shares
5 transactions
Others Institutions Holding LAB
# of Institutions
158Shares Held
279MCall Options Held
6KPut Options Held
36.6K-
Casdin Capital, LLC New York, NY76.1MShares$106 Million9.61% of portfolio
-
Viking Global Investors LP58.7MShares$81.5 Million0.21% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$30.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.2MShares$23.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY10.7MShares$14.9 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $109M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...